Analysts are predicting that a combination of Merck’s Keytruda and Pfizer’s Inlyta will become the standard of care in renal cell carcinoma (RCC) thanks to impressive trial results and a price ...

'We don't cower': Local community celebrates Hanukkah in wake of deadly terrorist attack As Jews and non-Jews alike mingled over hot cocoa, Cincinnati SWAT officers were on standby. Greater Cincinnati ...

Doechii has never been one to hide her beauty secrets and her latest video is the perfect proof. The Florida native is currently on the road for her Live from the Swamp Tour and she's letting us all ...

A phase 3, randomized, open-label trial enrolled 535 patients who were randomly assigned 1:1:1 to receive acalabrutinib-obinutuzumab (n = 179), acalabrutinib monotherapy (n = 179), or ...

We may receive a commission on purchases made from links. This is a decent markdown of 34% off of its original retail price of $189.99. For this discounted rate, you receive a Greenworks 40-volt ...

New York Post may be compensated and/or receive an affiliate commission if you click or buy through our links. Featured pricing is subject to change. OK, here’s my full-throttle, fun-loving ode to a ...

With the release date of Rajinikanth’s highly anticipated film Coolie set for August 14, 2025, the hype is already in full throttle. In an eye-catching move, Uno Aqua Care declared a full holiday for ...

Tristan Jurkovich began his career as a journalist in 2011. His childhood love of video games and writing fuel his passion for archiving this great medium’s history. He dabbles in every genre, but ...

Dr. Matthew Galsky highlights the impact of Imfinzi’s adjuvant approval for patients with muscle-invasive bladder cancer following cystectomy and chemotherapy. Adjuvant treatment with Imfinzi ...